SNDL
SNDL, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · CA
$1.37
+0.74%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 20.42x
- P/S forward
- 0.51x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.44x
- Price / sales
- 0.51x
- Price / cash flow
- 7.35x
Enterprise value
- Enterprise value
- $322.7M
- EV / sales
- 0.49x
- EV / EBITDA
- 12.07x
- EV / EBIT
- -28.63x
- Market cap
- $337.2M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026